Article
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
Science translational medicine - 18 Jul 2018
Richmond Jillian M, Strassner James P, Zapata Lucio, Garg Madhuri, Riding Rebecca L, Refat Maggi A, Fan Xueli, Azzolino Vincent, Tovar-Garza Andrea, Tsurushita Naoya, Pandya Amit G, Tso J Yun, Harris John E
Abstract excerpt
Vitiligo is an autoimmune disease of the skin mediated by CD8+ T cells that kill melanocytes and create white spots. Skin lesions in vitiligo frequently return after discontinuing conventional treatments, supporting the hypothesis that autoimmune memory is formed at these locations. We found that lesional T cells in mice and humans with vitiligo display a resident memory (TRM) phenotype, similar to those that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
